| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/07/2013 | WO2013017650A2 Formulations containing saccharomyces boulardii and superoxide dismutase (sod) to control obesity |
| 02/07/2013 | WO2013016807A1 Insulin secretion promoting agents |
| 02/07/2013 | US20130036481 Use of perlecan domain v in treating amyloidogenic disease |
| 02/07/2013 | US20130035380 Process for selective extraction of bioactive and bioavailable cinnamon polyphenols and procyanidin oligomers and a stable composition thereof |
| 02/07/2013 | US20130035378 Film delivery system for tetrahydrolipstatin |
| 02/07/2013 | US20130035371 Lipid formulated dsrna targeting the pcsk9 gene |
| 02/07/2013 | US20130035364 Benzylidene-indolinone compounds and their medical use |
| 02/07/2013 | US20130035363 Thalidomide Analogs |
| 02/07/2013 | US20130035354 Aryl pyridine as aldosterone synthase inhibitors |
| 02/07/2013 | US20130035347 Aromatic bycyclic derivatives as cxcr4 receptor modulators |
| 02/07/2013 | US20130035339 Apoptosis signal-regulating kinase inhibitors |
| 02/07/2013 | US20130035337 Fused bicyclic heteroaryl derivative |
| 02/07/2013 | US20130035327 Modulators of ATP-Binding Cassette Transporters |
| 02/07/2013 | US20130035326 Biaryl compounds and methods of use thereof |
| 02/07/2013 | US20130035324 Heterocyclic compounds and uses thereof |
| 02/07/2013 | US20130035312 Cathepsin cysteine protease inhibiors |
| 02/07/2013 | US20130035311 Prochelators for inhibiting metal-promoted oxidative stress |
| 02/07/2013 | US20130035293 Compositions and methods for modulating dopamine neurotransmission |
| 02/07/2013 | US20130035286 Pharmaceutical Composition Comprising Cyclic Somatostatin Analogues |
| 02/07/2013 | US20130035285 Novel glucagon analogues |
| 02/07/2013 | US20130035282 Metabolic and cardioprotection by the myokine follistatin-like 1 polypeptide |
| 02/07/2013 | US20130035281 Pharmaceutical composition, methods for treating and uses thereof |
| 02/07/2013 | US20130035280 Method and means for identifying substances which inhibit IgE production |
| 02/07/2013 | US20130034606 Immediate release tablet formulations |
| 02/07/2013 | US20130034602 Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery |
| 02/07/2013 | US20130034601 Method for increasing lactose tolerance in mammals exhibiting lactose intolerance |
| 02/07/2013 | US20130034599 Synthetic nanostructures including nucleic acids and/or other entities |
| 02/07/2013 | US20130034590 Delivery of Hydrophilic Drugs |
| 02/07/2013 | US20130034589 pH-SENSITIVE NANOPARTICLES FOR ORAL INSULIN DELIVERY |
| 02/07/2013 | US20130034569 Il-18 receptor antigen binding proteins |
| 02/07/2013 | US20130034568 Methods of treating or preventing periodontitis and diseases associated with periodontitis |
| 02/07/2013 | US20130034562 Selective androgen receptor modulators for treating diabetes |
| 02/07/2013 | US20130034553 Fusion Polypeptides Capable of Activating Receptors |
| 02/07/2013 | US20130034543 Modulating xrn1 |
| 02/07/2013 | US20130034539 Sr-bi as a predictor of human female infertility and responsiveness to treatment |
| 02/07/2013 | US20130034537 Simultaneous co-treatment of physical and mental symptoms related to severe mental disorders by a specially fermented soy formulation (fsww08) |
| 02/07/2013 | US20130034535 Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (cvd) and diabetics |
| 02/07/2013 | US20130034530 Dietary Supplement Cognitive Support System |
| 02/07/2013 | US20130034526 Populations of pancreatic progenitor cells and methods of isolating and using same |
| 02/07/2013 | US20130034525 Beta iselets-like cells derived from whole bone marrow |
| 02/07/2013 | US20130034495 Isotopologues of 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol |
| 02/07/2013 | CA2843794A1 Formulations containing saccharomyces boulardii and superoxide dismutase (sod) to control obesity |
| 02/07/2013 | CA2843672A1 Long-acting growth hormone and methods of producing same |
| 02/07/2013 | CA2843401A1 3-hydroxyanthranilic acid (3-haa) therapy for prevention and treatment of hyperlipidemia and its cardiovascular complications |
| 02/07/2013 | CA2843238A1 N-hetero-ring-substituted amide derivative |
| 02/07/2013 | CA2843224A1 Treatment of type 2 diabetes with fty720 |
| 02/07/2013 | CA2842802A1 Non-digestible capsules for the delivery of fluid absorbing materials |
| 02/07/2013 | CA2842450A1 Insulin secretion promoting agents |
| 02/07/2013 | CA2841572A1 Trans-clomiphene metabolites and uses thereof |
| 02/06/2013 | EP2554552A1 Novel anti-cd98 antibody and use thereof |
| 02/06/2013 | EP2554542A1 Phenylalanine derivative salt crystal |
| 02/06/2013 | EP2554183A1 Pharmaceutical composition comprising a GLP-1-agonist, an insulin, and methionine |
| 02/06/2013 | EP2554168A1 Controlled release pharmaceutical composition |
| 02/06/2013 | EP2554166A1 Oil and fat composition for prevention or treatment of diabetes |
| 02/06/2013 | EP2554165A1 Prophylactic agent or therapeutic agent for diabetes or obesity |
| 02/06/2013 | EP2552909A1 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists |
| 02/06/2013 | EP2552486A1 Transdermal delivery patch |
| 02/06/2013 | EP2552472A2 Anti-inflammatory factors |
| 02/06/2013 | EP2552463A1 Proangiogenic compositions, method for preparing same, and uses thereof |
| 02/06/2013 | EP2552442A1 Pharmaceutical composition comprising an sglt2 inhibitor and a ppar- gamma agonist and uses thereof |
| 02/06/2013 | EP2552407A1 Composition comprising insulin and herbal oil for transdermal or transmucosal administration |
| 02/06/2013 | EP2552242A1 Low protein infant formula with increased essential amino acids |
| 02/06/2013 | EP2552209A1 Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use |
| 02/06/2013 | CN102918046A Inhibitors of jnk |
| 02/06/2013 | CN102918035A 2 -amino- pyrimidine derivatives useful as inhibitors of jnk |
| 02/06/2013 | CN102918027A Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| 02/06/2013 | CN102917723A Soybean protein hydrolysate-containing antioxidant and use thereof |
| 02/06/2013 | CN102917715A Prophylactic/ameliorating agent for diseases, endurance improving agent and anti-fatigue agent, and pharmaceutical agent, food and beverage each comprising any one of those agents |
| 02/06/2013 | CN102917713A Proangiogenic compositions, method for preparing same, and uses thereof |
| 02/06/2013 | CN102917711A Heparan sulfate replacement therapy |
| 02/06/2013 | CN102917705A PPAR-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases |
| 02/06/2013 | CN102911222A Extraction method of aucubin and application of aucubin |
| 02/06/2013 | CN102911179A Lcotinib hydrochloride crystal form, medicinal composition and application |
| 02/06/2013 | CN102911069A L-carnitine calcium citrate and preparation method and application thereof |
| 02/06/2013 | CN102911068A L-carnitine L-malate, and preparation method and application thereof |
| 02/06/2013 | CN102911067A L-carnitine pyruvate, and preparation method and application thereof |
| 02/06/2013 | CN102908707A Hui medicine oxygen mask and matched medical oxygen medicated pad as well as preparation method of medicated pad |
| 02/06/2013 | CN102908627A pH-sensitive nanoparticles for oral insulin delivery |
| 02/06/2013 | CN102908621A New application of miRNAs for regulating insulin sensitivity as target |
| 02/06/2013 | CN102908599A Medicine capable of reducing blood sugar, blood fat and blood pressure |
| 02/06/2013 | CN102908589A Composite medicament for treating diabetic feet and preparation method thereof |
| 02/06/2013 | CN102908552A Preparation method of pig pancreas and autumn silkworm powder for treating diabetes |
| 02/06/2013 | CN102908538A Extraction method of corn stigma total flavonoids |
| 02/06/2013 | CN102908505A Preparation method of powder containing pig's pancreas and Chinese yam |
| 02/06/2013 | CN102908466A Propolis dropping pills and preparation method thereof |
| 02/06/2013 | CN102908453A Double-tonifying pills |
| 02/06/2013 | CN102908437A Chinese medicinal soft capsule |
| 02/06/2013 | CN102908425A Medicine for treating heart diseases and thick blood lipid and preparation method of the medicine |
| 02/06/2013 | CN102908413A Medicament for functional shoe for recuperating diabetes mellitus |
| 02/06/2013 | CN102908404A Method for extracting total saponin from polygala aureocauda Dunn |
| 02/06/2013 | CN102908399A A composition containing desert cistanche or cynomorium songaricum or medlar, lecithin and vitamin E |
| 02/06/2013 | CN102908387A Application of clerodendranthus spicatus in preparation of diet pills |
| 02/06/2013 | CN102908374A Method for extracting total saponin from kalopanax septemlobus leaves |
| 02/06/2013 | CN102908369A Process for preparing shiitake extract |
| 02/06/2013 | CN102908359A Composite calcium carbonate/vitamin D3 granules for children and preparation method thereof |
| 02/06/2013 | CN102908354A Preparation method of butafosfan injection |
| 02/06/2013 | CN102908351A Dipeptidyl peptidase inhibitors for treating diabetes |
| 02/06/2013 | CN102908350A Dipeptidyl peptidase inhibitors for treating diabetes |
| 02/06/2013 | CN102908349A Metformin hydrochloride compound medicament |
| 02/06/2013 | CN102908343A Composition capable of lowering blood fat and improving high density lipoprotein cholesterol and preparation method |